BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 25304123)

  • 21. Continuous positive airway pressure devices for the treatment of obstructive sleep apnoea-hypopnoea syndrome: a systematic review and economic analysis.
    McDaid C; Griffin S; Weatherly H; Durée K; van der Burgt M; van Hout S; Akers J; Davies RJ; Sculpher M; Westwood M
    Health Technol Assess; 2009 Jan; 13(4):iii-iv, xi-xiv, 1-119, 143-274. PubMed ID: 19103134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Financial Analysis of an Intensive Pediatric Continuous Positive Airway Pressure Program.
    Riley EB; Fieldston ES; Xanthopoulos MS; Beck SE; Menello MK; Matthews E; Marcus CL
    Sleep; 2017 Feb; 40(2):. PubMed ID: 28364508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adherence-based coverage of positive airway pressure treatment for sleep apnea: the 'brave new world' of cost-saving strategies.
    Brown LK
    Curr Opin Pulm Med; 2011 Nov; 17(6):403-5. PubMed ID: 21921794
    [No Abstract]   [Full Text] [Related]  

  • 24. [Continuous positive airway pressure in obstructive sleep apnea].
    Meurice JC; Antone E; Gilbert M; Watrin A; Bironneau V
    Presse Med; 2017 Apr; 46(4):423-431. PubMed ID: 28434626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medicare long-term CPAP coverage policy: a cost-utility analysis.
    Billings ME; Kapur VK
    J Clin Sleep Med; 2013 Oct; 9(10):1023-9. PubMed ID: 24127146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An economic analysis of continuous positive airway pressure for the treatment of obstructive sleep apnea-hypopnea syndrome.
    Weatherly HL; Griffin SC; Mc Daid C; Durée KH; Davies RJ; Stradling JR; Westwood ME; Sculpher MJ
    Int J Technol Assess Health Care; 2009 Jan; 25(1):26-34. PubMed ID: 19126248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of long-term adherence to continuous positive airway pressure in patients with obstructive sleep apnea and cardiovascular disease.
    Van Ryswyk E; Anderson CS; Antic NA; Barbe F; Bittencourt L; Freed R; Heeley E; Liu Z; Loffler KA; Lorenzi-Filho G; Luo Y; Margalef MJM; McEvoy RD; Mediano O; Mukherjee S; Ou Q; Woodman R; Zhang X; Chai-Coetzer CL
    Sleep; 2019 Oct; 42(10):. PubMed ID: 31587046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The economic impact of obstructive sleep apnea.
    AlGhanim N; Comondore VR; Fleetham J; Marra CA; Ayas NT
    Lung; 2008; 186(1):7-12. PubMed ID: 18066623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Effect of Patient Neighborhood Income Level on the Purchase of Continuous Positive Airway Pressure Treatment among Patients with Sleep Apnea.
    Kendzerska T; Gershon AS; Tomlinson G; Leung RS
    Ann Am Thorac Soc; 2016 Jan; 13(1):93-100. PubMed ID: 26473580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determinants affecting initiation of continuous positive airway pressure treatment.
    Brin YS; Reuveni H; Greenberg S; Tal A; Tarasiuk A
    Isr Med Assoc J; 2005 Jan; 7(1):13-8. PubMed ID: 15658139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Social factors associated with CPAP acceptance.
    Aloia MS
    Sleep; 2009 Apr; 32(4):443-4. PubMed ID: 19413139
    [No Abstract]   [Full Text] [Related]  

  • 32. [Probabilistic cost-effectiveness analysis of the treatment of sleep apnea].
    Mar J; Gutiérrez-Moreno S; Chilcott J
    Gac Sanit; 2006; 20(1):47-53. PubMed ID: 16539993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness of oral appliances in the treatment of obstructive sleep apnoea-hypopnoea.
    Sadatsafavi M; Marra CA; Ayas NT; Stradling J; Fleetham J
    Sleep Breath; 2009 Aug; 13(3):241-52. PubMed ID: 19229577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of long-term adherence to continuous positive airway pressure therapy in patients with obstructive sleep apnea and cardiovascular disease in the SAVE study.
    Chai-Coetzer CL; Luo YM; Antic NA; Zhang XL; Chen BY; He QY; Heeley E; Huang SG; Anderson C; Zhong NS; McEvoy RD
    Sleep; 2013 Dec; 36(12):1929-37. PubMed ID: 24293768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term prediction of adherence to continuous positive air pressure therapy for the treatment of moderate/severe obstructive sleep apnea syndrome.
    Baratta F; Pastori D; Bucci T; Fabiani M; Fabiani V; Brunori M; Loffredo L; Lillo R; Pannitteri G; Angelico F; Del Ben M
    Sleep Med; 2018 Mar; 43():66-70. PubMed ID: 29482815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular outcomes of CPAP therapy in obstructive sleep apnea syndrome.
    McNicholas WT
    Am J Physiol Regul Integr Comp Physiol; 2007 Oct; 293(4):R1666-70. PubMed ID: 17634199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Telemonitoring of CPAP therapy may save nursing time.
    Anttalainen U; Melkko S; Hakko S; Laitinen T; Saaresranta T
    Sleep Breath; 2016 Dec; 20(4):1209-1215. PubMed ID: 27043327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of continuous positive airway pressure (CPAP) therapy on IL-23 in patients with obstructive sleep apnea.
    Can M; Uygur F; Tanrıverdi H; Acıkgoz B; Alper B; Guven B
    Immunol Res; 2016 Dec; 64(5-6):1179-1184. PubMed ID: 27665460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Continuous positive airway pressure therapy: new generations.
    Garvey JF; McNicholas WT
    Indian J Med Res; 2010 Feb; 131():259-66. PubMed ID: 20308751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The value of auto-adjustable CPAP devices in pressure titration and treatment of patients with obstructive sleep apnea syndrome.
    Hertegonne K; Bauters F
    Sleep Med Rev; 2010 Apr; 14(2):115-9. PubMed ID: 19716321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.